268. Nakajo-Nishimura syndrome Disease details / Clinical trials / Drug dev / DR info

Clinical trial : 0 / Drug : 0 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0

Nakajo-Nishimura syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
IDDiseases (Sorted by drug repositionability)
268Nakajo-Nishimura syndrome
325Hereditary autoinflammatory syndrome
46Malignant rheumatoid arthritis
49Systemic lupus erythematosus
51Scleroderma
65Primary immunodeficiency
84Sarcoidosis
96Crohn disease
256Muscle glycogenosis
53Sjogren syndrome
271Ankylosing spondylitis
162Pemphigoid
228Bronchiolitis obliterans
265Lipodystrophy
93Primary biliary cholangitis
50Dermatomyositis
107Juvenile idiopathic arthritis
97Ulcerative colitis
40Takayasu arteritis
41Giant cell arteritis
269Pyogenic arthritis
11Myasthenia gravis
44Wegener granulomatosis